DK175801B1 - Anvendelse af substituerede alkylidendithio-bis-(substituerede)-phenoler til fremstilling af et lægemiddel til inhibering af interleukin-1-medierede virkninger bortset fra atherosklerose og/eller hyperlipidæmi - Google Patents

Anvendelse af substituerede alkylidendithio-bis-(substituerede)-phenoler til fremstilling af et lægemiddel til inhibering af interleukin-1-medierede virkninger bortset fra atherosklerose og/eller hyperlipidæmi Download PDF

Info

Publication number
DK175801B1
DK175801B1 DK198801433A DK143388A DK175801B1 DK 175801 B1 DK175801 B1 DK 175801B1 DK 198801433 A DK198801433 A DK 198801433A DK 143388 A DK143388 A DK 143388A DK 175801 B1 DK175801 B1 DK 175801B1
Authority
DK
Denmark
Prior art keywords
use according
methyl
butyl
probucol
ethyl
Prior art date
Application number
DK198801433A
Other languages
Danish (da)
English (en)
Other versions
DK143388A (da
DK143388D0 (da
Inventor
George Ku
Niall Doherty
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK143388D0 publication Critical patent/DK143388D0/da
Publication of DK143388A publication Critical patent/DK143388A/da
Application granted granted Critical
Publication of DK175801B1 publication Critical patent/DK175801B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK198801433A 1987-03-17 1988-03-16 Anvendelse af substituerede alkylidendithio-bis-(substituerede)-phenoler til fremstilling af et lægemiddel til inhibering af interleukin-1-medierede virkninger bortset fra atherosklerose og/eller hyperlipidæmi DK175801B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2658687A 1987-03-17 1987-03-17
US2658687 1987-03-17
US15157288A 1988-02-18 1988-02-18
US15157288 1988-02-18

Publications (3)

Publication Number Publication Date
DK143388D0 DK143388D0 (da) 1988-03-16
DK143388A DK143388A (da) 1988-09-18
DK175801B1 true DK175801B1 (da) 2005-02-28

Family

ID=26701419

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198801433A DK175801B1 (da) 1987-03-17 1988-03-16 Anvendelse af substituerede alkylidendithio-bis-(substituerede)-phenoler til fremstilling af et lægemiddel til inhibering af interleukin-1-medierede virkninger bortset fra atherosklerose og/eller hyperlipidæmi

Country Status (10)

Country Link
EP (1) EP0292660B1 (enExample)
JP (1) JP2671129B2 (enExample)
KR (1) KR960005704B1 (enExample)
AU (1) AU602961B2 (enExample)
DE (1) DE3869202D1 (enExample)
DK (1) DK175801B1 (enExample)
ES (1) ES2039489T3 (enExample)
GR (1) GR3004108T3 (enExample)
IE (1) IE60708B1 (enExample)
PH (1) PH23885A (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959392A (en) * 1989-07-24 1990-09-25 Merrell Dow Pharmaceuticals Inc. Method of treating diabetes mellitus
AU651873B2 (en) * 1991-03-18 1994-08-04 Merrell Dow Pharmaceuticals Inc. Method of inhibiting the progressive development of diabetes mellitus
FI951367A7 (fi) * 1994-03-28 1995-09-29 Japan Energy Corp Puriinijohdannaiset ja tulehdustautien tukahduttajat (suppressantit)
AU2006202461B2 (en) * 1997-05-14 2009-12-03 Atherogenics, Inc. Compositions and methods for the inhibition of the expression of VCAM-1
US6852878B2 (en) 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
TR199902802T2 (xx) 1997-05-14 2000-04-21 Atherogenics, Inc. Kardiyovask�ler hastal�klar ve enflamatuar hastal�klar�n tedavisi i�in probukol monoesterleri.
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
EP1695959A1 (en) * 1997-05-14 2006-08-30 Atherogenics, Inc. Compouds and methods for the inhibition of the expression of VCAM-1
KR20010020611A (ko) 1997-07-01 2001-03-15 아테로제닉스, 인코포레이티드 항산화제에 의한 과증식질병 치료의 향상
EP1272465A2 (en) 2000-04-11 2003-01-08 Atherogenics, Inc. Compounds and methods to increase plasma hdl cholesterol levels and improve hdl functionality
BRPI0809423A2 (pt) 2007-03-26 2014-09-09 Salutria Pharmaceuticals Llc Usos e composições de derivados de probucol para o tratamento de diabetes
CN108299263B (zh) * 2018-01-30 2020-12-01 北京德默高科医药技术有限公司 一种普罗布考衍生物及其制备方法与应用

Also Published As

Publication number Publication date
IE880786L (en) 1988-09-17
KR880010766A (ko) 1988-10-24
KR960005704B1 (ko) 1996-05-01
GR3004108T3 (enExample) 1993-03-31
JP2671129B2 (ja) 1997-10-29
AU1316088A (en) 1988-09-15
DK143388A (da) 1988-09-18
DK143388D0 (da) 1988-03-16
EP0292660B1 (en) 1992-03-18
EP0292660A3 (en) 1990-03-28
AU602961B2 (en) 1990-11-01
ES2039489T3 (es) 1993-10-01
DE3869202D1 (de) 1992-04-23
PH23885A (en) 1989-12-18
EP0292660A2 (en) 1988-11-30
IE60708B1 (en) 1994-08-10
JPS63258408A (ja) 1988-10-25

Similar Documents

Publication Publication Date Title
US4975467A (en) Method of inhibiting interleukin-1 release and alleviating interleukin-1 mediated conditions
US8080527B2 (en) Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection
DK175801B1 (da) Anvendelse af substituerede alkylidendithio-bis-(substituerede)-phenoler til fremstilling af et lægemiddel til inhibering af interleukin-1-medierede virkninger bortset fra atherosklerose og/eller hyperlipidæmi
EP1071417B1 (en) Use of cannabidiol as anti-inflammatory agent
MX2011001426A (es) Metodos para tratar la talasemia.
RU2057120C1 (ru) N-алкил-3-фенил-3-(2-замещенный фенокси)пропиламин или его фармацевтически приемлемая кислотно-аддитивная соль, способ его получения, фармацевтическая композиция, обладающая ингибирующей поглощение норминефрина активностью
EP3786158A1 (en) Cyclohexenyl compounds, compositions comprising them and uses thereof
EP0038343A1 (de) Substituierte oxocarbonsäuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel.
AU601554B2 (en) Method of inhibiting interleukin-1 release
WO2011012868A1 (en) Compounds for treatment of inflammation
RU2396075C2 (ru) Применение n-(2-арилпропионил)сульфонамидов для лечения повреждения спинного мозга
US4540709A (en) Method for treatment of diseases mediated by PAF using 5-allyl-2-(3,4-Dimethoxyphenyl)-3a,α-methoxy-3-methyl-2,3,3a,6-tetrahydro-6-oxobenzofuran
US5789446A (en) Therapeutic agent for treating joint diseases associated with arthritis
KR102316961B1 (ko) 면역억제제로서의 벤젠 유도체의 면역억제용 약학적 조성물
CH650776A5 (fr) Derives de la pyrimidine, leur procede de preparation et les compositions therapeutiques les contenant.
HU227927B1 (hu) Helyettesített 6-(dimetilamino-metil)-1-fenil-ciklohexán-vegyületek felhasználása vizelet-inkontinencia kezelésére
JPH01500270A (ja) ５‐ヘテロ‐またはアリール‐置換された‐イミダゾ［２，１‐ａ］イソキノリン類
US20260007640A1 (en) Compositions for the treatment of inflammatory disorders
JPWO2020004404A1 (ja) ＩＬ−１β阻害薬
WO1999026624A1 (en) Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhe and scours
WO2013001490A1 (en) Novel anti-inflammatory dihydrochalcone derivatives and use thereof
US5034412A (en) Method of inhibiting interleukin-1 release
KR950008206B1 (ko) 2-클로로-4-((시아노메틸)티오)페닐 n-메틸 카바메이트 및 이의 제조방법, 및 이를 함유하는 약제학적 조성물
CN119584967A (zh) 用甘氨酸转运抑制剂治疗肝性卟啉症的组合物和方法
JPH0892079A (ja) ヒスタミン遊離抑制剤

Legal Events

Date Code Title Description
PUP Patent expired